文献
J-GLOBAL ID:201802254086821848
整理番号:18A1309220
先進治療薬のマーケティング認可のためのEUの意思決定:事例研究【JST・京大機械翻訳】
EU decision-making for marketing authorization of advanced therapy medicinal products: a case study
著者 (9件):
de Wilde Sofieke
(Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands)
,
Coppens Delphi G.M.
(Utrecht Institute for Pharmaceutical Sciences Utrecht University, Utrecht, The Netherlands)
,
Hoekman Jarno
(Utrecht Institute for Pharmaceutical Sciences Utrecht University, Utrecht, The Netherlands)
,
Hoekman Jarno
(Innovation Studies Group, Faculty of Geosciences, Utrecht University, Utrecht, The Netherlands)
,
de Bruin Marie L.
(Utrecht Institute for Pharmaceutical Sciences Utrecht University, Utrecht, The Netherlands)
,
de Bruin Marie L.
(Copenhagen Centre for Regulatory Science, University of Copenhagen, Copenhagen, Denmark)
,
Leufkens Hubert G.M.
(Utrecht Institute for Pharmaceutical Sciences Utrecht University, Utrecht, The Netherlands)
,
Guchelaar Henk-Jan
(Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands)
,
Meij Pauline
(Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands)
資料名:
Drug Discovery Today
(Drug Discovery Today)
巻:
23
号:
7
ページ:
1328-1333
発行年:
2018年
JST資料番号:
W1088B
ISSN:
1359-6446
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)